Those who suffer from poor sleep quality, including daytime sleepiness, snoring, or getting too much or too little sleep, are at increased risk of developing glaucoma.
Researchers have developed a new ophthalmological device that can detect degenerative visual problems such as age-related macular degeneration long before the onset of the first symptoms.
Gene therapy enables a striking recovery of night vision in those who suffer from the childhood-onset blindness disorder Leber Congenital Amaurosis.
Administering a chemical compound called synthetic retinoids to the retina helped restore brain networks associated with vision and prompted the growth of two times more neurons, effectively restoring vision in adult mouse models of the genetic visual disorder LCA.
People with normal-tension glaucoma are at increased risk of developing Alzheimer's disease, researchers say.
Study reveals how changes in pupil size affect the way we perceive our surroundings.
People who use reusable contact lenses rather than disposable daily lenses are four times more likely to develop Acanthamoeba keratitis, a corneal infection that can cause sight loss.
The loss of blood flow autoregulation caused by diabetes is the result of the disruption of the TRPV2 protein. Even in the absence of diabetes, disrupted blood flow autoregulation causes damage closely resembling that seen in diabetic retinopathy.
Neurons in the midbrain receive strong, specific synaptic input from retinal ganglion cells, but only from a small number of the sensory neurons.
Determining the structure of vitronectin, a protein implicated in age-related macular degeneration and some neurodegenerative disorders, and using pressure to alter the protein shape may help in the development of new treatments for AMD.
A new study reports that a new gene therapy shows promise in treating dry age-related macular degeneration. The gene therapy, ophNdi1, directly targets mitochondrial function that is malfunctioning in AMD.
Researchers partially restored the function of cone receptors in the retinas of children born completely blind by using gene therapy.
